Month: July 2011

The comment that Dr. Stanton found extraordinary reads as follows: “Collectively, these findings prove that reduced SGLT-2 activity—whether genetically or experimentally induced—is efficacious and relatively safe ….” (1). This sentence referred to the animal studies described in the preceding paragraph, as becomes even more apparent in the following sentence that reads: “The development of SGLT-2